Plain-English translation of NCT07399236 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are building an artificial intelligence tool that can predict whether colorectal cancer will return to the liver after surgery. The tool will analyze your pre-surgery CT scans, pathology slides, and medical history to identify patients at higher risk. This study uses only existing medical data—no new procedures or treatments.
After colorectal cancer surgery, some patients develop cancer in their liver months or years later, but doctors can't currently predict who is most at risk. This tool could help identify high-risk patients earlier so they can receive closer monitoring and more personalized treatment plans.
You likely qualify if…
You likely don't qualify if…
There are no visits or procedures for you. Researchers will gather your existing medical data—including your pre-surgery CT scans, pathology slides from your surgery, and clinical records—and use them to train and test the artificial intelligence model. This is a retrospective study, meaning it only uses data already collected during your routine care.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China